Fabry Disease Clinical Trial Pipeline Major pharmaceutical companies are working to advance the pipeline space and unlock the future growth ...

Mr Edwards is an accredited and experienced geologist with over 25 years’ of experience working primarily as a manager/mine geologist responsible for the definition and replacement of resources and ...

Since opening its doors in 1981, Nohra Haime Gallery has been recognized for its consistent representation of International, Latin American, sculpture and women artists, often exhibiting work that ...

Two of KSW’s top-ranked bantamweights faced off for the promotion’s vacant bantamweight title at KSW 102 on Saturday, January 25, 2025. The first event from the Polish org in 2025 saw the number one ...

Approved and upcoming products in the Fabry Disease market during the study period (2023–2032) include Venglustat (GZ402671), Isaralgagene civaparvovec (ST 920), and PRX-102 (Elfabrio).

Approved and upcoming products in the Fabry Disease market during the study period (2023–2032) include Venglustat (GZ402671), Isaralgagene civaparvovec (ST 920), and PRX-102 (Elfabrio). • In December ...

Chiesi UK & Ireland has published new research revealing significant gaps in the understanding and practice of inhaler use among UK asthma patients. The study published in the BMJ Open Respiratory ...

Tanimilast is under clinical development by Chiesi Farmaceutici and currently in Phase II for Asthma. According to GlobalData, Phase II drugs for Asthma have a 27% phase transition success rate (PTSR) ...

A pair of physicists at the University of Crete has found that some types of biological magnetoreceptors used by various creatures to navigate, operate at or near the quantum limit. In their paper ...

We’re big fans of the Tissot PRX here at T3, and now the Swiss watchmaker has expanded the range with two new colours to get excited about. The first is an ‘ice blue’ dial with stainless ...